Tuesday, August 4, 2026

South Korea Tightens Ebola Entry Controls While Assessing Importation Risk as Low

The Korea Disease Control Agency confirmed no Ebola virus cases in the country and added Ethiopia and Rwanda to the monitoring list.

North Korea’s Trash Balloons to Cost Over $15K in Property Damages

The property damage in the metropolitan area...

How SCL Science’s Digital Logistics Platform BIONECT is Revolutionizing the Cold Chain Industry

SCL Science showcased its next-gen bio-logistics platform at the Korea Cold Chain 2026, emphasizing advanced cold chain logistics for healthcare.

Tag: glucagon

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

MetaVia to Present DA-1726 Phase 1 Obesity Trial Data at EASL Congress 2026

Dong-A ST's Meta via will present DA-1726, a dual-action obesity treatment, at the EASL Congress 2026, showcasing promising clinical trial results.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.